Dr. Rakesh Mishra, Director, Tata Institute for Genetics and Society, India speaks to The Hindu on the COVID-19 pandemic, vaccines, variants and steps we need to take in order to ensure maximum safety, without hampering the economy.
16Feb
Related Posts
01Jul
Genetics has revolutionised patient selection for clinical trials
Vaccines are not necessarily the best or only therapy against a... read more
30Jan
Agricultural biotechnology: Gene editing versus gene modification, The Indian Express, 30 Jan 2020
06Dec
Healthcare to agriculture: How genome revolution could be game changer
Dr. Rakesh Mishra, Director at TIGS, and Dr. Saveetha Meganathan, Research Scientist... read more
21Apr
On rising Covid-19 cases
Mask is ‘super vaccine’, COVID-19 still a threat, say scientists "Hyderabad is... read more
04May
COVID-19 is airborne; Masks still essential to avoid the spread of virus, Collaborative Study reveals
In a collaborative study, it is found that, novel #Coronavirus is airborne... read more
11Jun
A-post-Covid-19 social protection architecture for India,Hindustan Times,11 Jun 2020
https://www.hindustantimes.com/analysis/a-post-covid-19-social-protection-architecture-for-india/story-BCt1POzFojnKloCkHTsv9H.html read more
30Jun
The impact of Next Generation Sequencing on human health and agriculture
Next-Generation Sequencing (NGS) denotes high-throughput sequencing in a massively parallel fashion... read more
12Mar
‘Not Done With Covid Pandemic Yet’: Experts Say Future Depends On New Variants, Need to be Watchful
“We should still wait to call the Covid pandemic has reached... read more
04Apr
Time to eliminate ‘silent killer’ TB, say top scientists
TIGS organised a webinar to mark world TB day 2022 on... read more